Inform Genomics And Translational Drug Development (TD2) Announce Strategic Collaboration

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOSTON, June 23, 2014 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a proprietary technology platform to discover and develop genomic-based, precision medicine products, and Translational Drug Development LLC (TD2) based in Scottsdale, Arizona, today announced a strategic collaboration leveraging Inform Genomics' proprietary technology platform and analytic capabilities to biopharmaceutical companies through TD2's oncology drug development services.

Help employers find you! Check out all the jobs and post your resume.

Back to news